CALR and myeloproliferative disorder: One example of this is mutations in the calreticulin (CALR) gene in patients with myeloproliferative neoplasms, with mutant-CALR eliciting antigen-specific responses from both CD4 + and CD8 + T cells, suggesting potential as a shared neoantigen [77].